Back to results
US 10,702,538 B2Granted
Ship inhibition to induce activation of natural killer cells
AssigneeThe Research Foundation for The State University of New York
InventorsWilliam Kerr, Matthew Gumbleton
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of SHIP1 inhibitors and pan-SHIP1/2 inhibitors in various methods, including, without limitation, a method of inhibiting SHIP to induce broad activation of natural killer (NK) cells to treat various diseases.
Claims18
A method of activating natural killer (NK) cells in a subject suffering from an illness or condition for which NK cells provide a host defense, said method comprising:
- periodically administering a safe and effective amount of a SHIP1 inhibitor to the subject, wherein an administration period is immediately followed by a rest period during which no SHIP1 inhibitor is administered, wherein a cycle of one administration period followed by one rest period is repeated, wherein the administration period has a duration of no less than two days, but no more than three days, and the rest period has a duration of between two and ten days, inclusive, and wherein periodic administration of the SHIP1 inhibitor activates NK cells in the subject.
Dependencies are inferred from the claim text.